Gilead Sciences

Open: 76.12 Close: 76.0 Change: -0.12

How to know if Gilead Sciences Company Inc is a risky investment without reading the whole internet.

Are looking for the most relevant information about Gilead Sciences? Investor spend a lot of time searching for information to make investment decisions in Gilead Sciences. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Gilead Sciences are: Sciences, Gilead, stock, GILD, price, analyst, Inc, and the most common words in the summary are: gilead, science, stock, inc, job, best, gild, . One of the sentences in the summary was: Gilead Sciences Inc. Other searches related to this term that the …

Concept Map

Semantic Network

Stock Summary

Gilead Sciences, Inc. discovers, develops, and commercializes medicines in the areas of unmet medical need. The company provides Biktarvy, Genvoya, Descovy, Descogna, Odefsey,.

Today's Summary

Gilead Sciences Inc. reported earnings per share of $1.89 for the current quarter. Wall Street analysts predict that Gileads s share price could reach $87.67 by Sep 8, 2024. Gileade Sciences stock price is 76.00 USD today.

Today's News

Gilead Sciences Inc. (GILD) up 1.70% in premarket trading. Bank of America: Gileads could jump nearly 30%. Gileades has more to offer than investors think, one analyst argued. Gilead Sciences Inc reported earnings per share of $1.89 for the current quarter. The Gileade Sciences stock price is 76.00 USD today. Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company is an equal opportunity employer, as an Equal Opportunity Employer. Gilead Sciences is holding a Zacks Rank of #3 (Hold) right now. Wall Street will be looking for positivity from the companys next earnings report date. Gilead Sciences, Inc. (GILD) stock price, quote & news - stock analysis. Gileads stock slides 2% after Q2 profit slides 2%, consensus and lowers guidance. Analyst Consensus: Buy Stock Forecasts. Wall Street analysts predict that Gilead Sciences s share price could reach $87.67 by Sep 8, 2024. Wall Street analyst consensus among 9 analysts covering ( NASDAQ : GILD ) stock is to Buy GILD stock. Average price target of $76.00 is 15.35% higher than current GILD share price.

Stock Profile

"Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, Trodelvy, and Zydelig products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. Gilead Sciences, Inc. has collaboration agreements with Arcus Biosciences, Inc.; Merck & Co, Inc.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Tango Therapeutics, Inc.; Jounce Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; and Merck & Co, Inc. The company was incorporated in 1987 and is headquartered in Foster City, California."

Keywords

The game is changing. There is a new strategy to evaluate Gilead Sciences fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Gilead Sciences are: Sciences, Gilead, stock, GILD, price, analyst, Inc, and the most common words in the summary are: gilead, science, stock, inc, job, best, gild, . One of the sentences in the summary was: Gilead Sciences Inc. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #gilead #science #stock #inc #job #best #gild.